I cannot overstate the importance of treating each biosimilar individually rather than as if they were a generic drug.
Joe Barton: “I cannot overstate the importance of treating each biosimilar individually rather than as if they were a generic drug.”
On the recordFebruary 3, 2016
Source
congress.govEditor's note · Context
Barton emphasizes the need for individual assessment of biosimilars.
Share
More from Joe Barton
Dec 11, 2018
Before Congressman Hensarling leaves, I just want to commend him for his service and tell him what a privilege it has been for me to serve with him and to know him as a friend. We are both retiring, and we are both, so far as I know, going…
Dec 12, 2018
I was in Senate Chamber trying to prevent a hold on H.R. 7217. I was unavoidably detained. Had I been present, I would have voted ``yea'' on rollcall No. 434. ____________________
Jul 16, 2018
It is not complicated if you are an elected member of Congress and all of a sudden Medicare recipients start showing up at their town, town hall.





